Related Experiment Videos
Transient gene expression by nonintegrating lentiviral vectors
Sarah J Nightingale1, Roger P Hollis, Karen A Pepper
1Division of Research Immunology/Bone Marrow Transplant, The Saban Research Institute of Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA 90027, USA.
Summary
Nonintegrating lentiviral (NIL) vectors enable efficient transient gene expression in cells. These disabled vectors show rapid loss of expression and minimal integration, offering a safer gene delivery tool.
Area of Science:
- Molecular Biology
- Gene Therapy
- Virology
Background:
- Lentiviral vectors are widely used for gene delivery.
- Ensuring transient gene expression and minimizing integration is crucial for safety.
Purpose of the Study:
- To develop and assess nonintegrating lentiviral (NIL) vectors for transient gene expression.
- To evaluate the efficacy and safety of NIL vectors in human cell lines and primary cells.
Main Methods:
- HIV-1-based lentiviral vectors were engineered with mutations disabling integrase and altering LTR recognition sequences.
- NIL vectors were used to transduce Jurkat cells and CD34(+) hematopoietic progenitor cells.
- Enhanced green fluorescent protein (eGFP) expression was monitored, and Southern blot analysis was performed.
Main Results:
- Highly disabled NIL vectors achieved high initial eGFP expression (approx. 90%) that diminished to background levels (<0.5%) within a month.
- Detectable NIL vector sequences were lost by 1 month post-transduction.
- Integration levels were reduced ~10(4)-fold compared to wild-type vectors, with rare events attributed to background recombination.
Conclusions:
- NIL vectors provide a novel tool for efficient transient gene expression.
- These vectors demonstrate reduced integration, enhancing safety for gene therapy applications.
- NIL vectors are suitable for use in primary stem cells and hematopoietic/lymphoid cells.